Follow
Neelakanta Dadi
Neelakanta Dadi
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Impact of nab–paclitaxel-based second-line chemotherapy in metastatic pancreatic cancer
N Dadi, M Stanley, S Shahda, BH O'NEIL, A Sehdev
Anticancer Research 37 (10), 5533-5539, 2017
192017
Real-world Data of Leukopenia Evaluation as Seen in a Community Academic Center
SS Chennapragada, S Sharma, N Dadi, R Shi, RP Mansour
Journal of Community Hospital Internal Medicine Perspectives 13 (6), 126, 2023
2023
Evaluation of the Efficacy of Flow-Cytometry in the Work-up of Leukopenia: An Institutional Retrospective Analysis
S Chennapragada, N Dadi, R Shi, RP Mansour
Blood 140 (Supplement 1), 7893-7894, 2022
2022
Outcomes of Salvage Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Meta-Analysis
N Dadi, V Vosuri, SR Master, RP Mansour
Blood 134, 5699, 2019
2019
Role of adjuvant chemotherapy in small (≤ 5 mm) node-negative and hormone receptor-negative breast cancer.
SR Master, N Dadi, C Shah, GV Burton, R Shi
Journal of Clinical Oncology 37 (15_suppl), e12021-e12021, 2019
2019
The impact of research presented at annual gastrointestinal cancers symposium.
A Sehdev, N Dadi, DA Haggstrom, LG Koniaris, BH O'Neil
Journal of Clinical Oncology 36 (4_suppl), 757-757, 2018
2018
Impact of nab-paclitaxel-based second-line chemotherapy on the outcomes of pancreatic cancer.
N Dadi, S Shahda, BH O'Neil, A Sehdev
Journal of Clinical Oncology 35 (4_suppl), 483-483, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–7